Divestiture of Gambro AB Completed

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Following approval by competition authorities, Investor’s divestiture of its holding in Gambro to Baxter International Inc., announced on December 4, 2012, has been completed. After net debt adjustments, total net proceeds to Investor will amount to SEK 10.2 bn., of which SEK 1.6 bn. from EQT. Of the total proceeds of SEK 10.2 bn., SEK 1.2 bn. will remain in escrow for 15 months.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC